Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?The expiration date of the key patent for guselkumab?When does guselkumab patent expire?When will a generic version of xiaflex be available?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for vascepa
No. Vascepa (icosapent ethyl) does not have a unique absorption mechanism. It’s an omega‑3 fatty acid ethyl ester (EPA ethyl ester), and its absorption uses the same general pathway as other fatty acid ethyl esters: - Taken with meals (especially fatty meals) to optimize absorption. - In the gut, pancreatic lipase hydrolyzes the ethyl ester to free EPA. - EPA is solubilized by bile acids and micelles, then absorbed into enterocytes. - Inside enterocytes, EPA is re-esterified and packaged into chylomicrons for lymphatic transport into the bloodstream. The main difference from some other fish-oil products is that Vascepa contains EPA only (no DHA) and is in the ethyl ester form; absorption kinetics can differ somewhat from EPA+DHA ethyl esters or triglyceride forms, but the basic absorption mechanism is standard for fatty acid ethyl esters. If you’d like, I can compare its PK more specifically to Lovaza or other formulations.
Other Questions About Vascepa :